Emilio Merlo Pich - Publications

Glaxo SmithKline, Verona, Italy, Verona, Veneto, Italy 

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Toth M, Flandreau EI, Deslauriers J, Geyer MA, Mansuy I, Merlo-Pich E, Risbrough V. Overexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26538448 DOI: 10.1038/npp.2015.338  0.52
2015 West PW, Canning BJ, Merlo-Pich E, Woodcock AA, Smith JA. Morphologic Characterization of Nerves in Whole-Mount Airway Biopsies. American Journal of Respiratory and Critical Care Medicine. 192: 30-9. PMID 25906337 DOI: 10.1164/rccm.201412-2293OC  0.52
2014 Merlo Pich E, Jeromin A, Frisoni GB, Hill D, Lockhart A, Schmidt ME, Turner MR, Mondello S, Potter WZ. Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology? Alzheimer's Research & Therapy. 6: 51. PMID 25484927 DOI: 10.1186/alzrt276  0.52
2014 Le Foll B, Collo G, Rabiner EA, Boileau I, Merlo Pich E, Sokoloff P. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings. Progress in Brain Research. 211: 255-75. PMID 24968784 DOI: 10.1016/B978-0-444-63425-2.00011-8  0.52
2014 Inamdar A, Merlo-Pich E, Gee M, Makumi C, Mistry P, Robertson J, Steinberg E, Zamuner S, Learned S, Alexander R, Ratti E. Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach. Journal of Psychopharmacology (Oxford, England). 28: 570-581. PMID 24699061 DOI: 10.1177/0269881114529377  0.52
2014 Faria V, Ahs F, Appel L, Linnman C, Bani M, Bettica P, Pich EM, Wahlstedt K, Fredrikson M, Furmark T. Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1149-57. PMID 24666527 DOI: 10.1017/S1461145714000352  0.72
2014 Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN, Beaver JD, Waldman A, Nutt DJ, Bani M, Merlo-Pich E, Rabiner EA, Lingford-Hughes A. In vivo imaging of cerebral dopamine D3 receptors in alcoholism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1703-12. PMID 24469594 DOI: 10.1038/npp.2014.18  0.52
2014 Giménez M, Ortiz H, Soriano-Mas C, López-Solà M, Farré M, Deus J, Martín-Santos R, Fernandes S, Fina P, Bani M, Zancan S, Pujol J, Merlo-Pich E. Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: initial validation of an imaging protocol for drug discovery. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 105-16. PMID 24332890 DOI: 10.1016/j.euroneuro.2013.09.004  0.52
2014 Toth M, Gresack JE, Bangasser DA, Plona Z, Valentino RJ, Flandreau EI, Mansuy IM, Merlo-Pich E, Geyer MA, Risbrough VB. Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1409-19. PMID 24326400 DOI: 10.1038/npp.2013.336  0.52
2014 Poma SZ, Merlo-Pich E, Bettica P, Bani M, Fina P, Ziviani L, Milleri S. Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge. Journal of Psychopharmacology (Oxford, England). 28: 491-7. PMID 24108409 DOI: 10.1177/0269881113507641  0.52
2013 Ratti E, Carpenter DJ, Zamuner S, Fernandes S, Squassante L, Danker-Hopfe H, Archer G, Robertson J, Alexander R, Trist DG, Merlo-Pich E. Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia. Sleep. 36: 1823-30. PMID 24293756 DOI: 10.5665/sleep.3208  0.52
2013 Gozzi A, Lepore S, Vicentini E, Merlo-Pich E, Bifone A. Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2120-30. PMID 23736277 DOI: 10.1038/npp.2013.109  0.52
2013 Searle GE, Beaver JD, Tziortzi A, Comley RA, Bani M, Ghibellini G, Merlo-Pich E, Rabiner EA, Laruelle M, Gunn RN. Mathematical modelling of [¹¹C]-(+)-PHNO human competition studies. Neuroimage. 68: 119-32. PMID 23207573 DOI: 10.1016/j.neuroimage.2012.11.033  0.52
2013 Mugnaini M, Iavarone L, Cavallini P, Griffante C, Oliosi B, Savoia C, Beaver J, Rabiner EA, Micheli F, Heidbreder C, Andorn A, Merlo Pich E, Bani M. Occupancy of brain dopamine D3 receptors and drug craving: a translational approach. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 302-12. PMID 22968817 DOI: 10.1038/npp.2012.171  0.52
2013 Pujol J, Giménez M, Ortiz H, Soriano-Mas C, López-Solà M, Farré M, Deus J, Merlo-Pich E, Harrison BJ, Cardoner N, Navinés R, Martín-Santos R. Neural response to the observable self in social anxiety disorder. Psychological Medicine. 43: 721-31. PMID 22895096 DOI: 10.1017/S0033291712001857  0.52
2012 Pich EM, Vargas G, Domenici E. Biomarkers for antipsychotic therapies. Handbook of Experimental Pharmacology. 339-60. PMID 23129338 DOI: 10.1007/978-3-642-25761-2_13  0.72
2012 Giménez M, Pujol J, Ortiz H, Soriano-Mas C, López-Solà M, Farré M, Deus J, Merlo-Pich E, Martín-Santos R. Altered brain functional connectivity in relation to perception of scrutiny in social anxiety disorder. Psychiatry Research. 202: 214-23. PMID 22809740 DOI: 10.1016/j.pscychresns.2011.10.008  0.52
2012 Faedo S, Perdonà E, Antolini M, di Fabio R, Merlo Pich E, Corsi M. Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists. European Journal of Pharmacology. 692: 1-9. PMID 22796453 DOI: 10.1016/j.ejphar.2012.07.007  0.52
2012 Mogg K, Bradley BP, O'Neill B, Bani M, Merlo-Pich E, Koch A, Bullmore ET, Nathan PJ. Effect of dopamine D₃ receptor antagonism on approach responses to food cues in overweight and obese individuals. Behavioural Pharmacology. 23: 603-8. PMID 22772335 DOI: 10.1097/FBP.0b013e3283566a4a  0.52
2012 Piccoli L, Micioni Di Bonaventura MV, Cifani C, Costantini VJ, Massagrande M, Montanari D, Martinelli P, Antolini M, Ciccocioppo R, Massi M, Merlo-Pich E, Di Fabio R, Corsi M. Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1999-2011. PMID 22569505 DOI: 10.1038/npp.2012.48  0.52
2012 Dodds CM, O'Neill B, Beaver J, Makwana A, Bani M, Merlo-Pich E, Fletcher PC, Koch A, Bullmore ET, Nathan PJ. Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters. Appetite. 59: 27-33. PMID 22445776 DOI: 10.1016/j.appet.2012.03.007  0.52
2012 Collo G, Bono F, Cavalleri L, Plebani L, Merlo Pich E, Millan MJ, Spano PF, Missale C. Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways. Journal of Neurochemistry. 120: 765-78. PMID 22145570 DOI: 10.1111/j.1471-4159.2011.07618.x  0.52
2012 Meunier D, Ersche KD, Craig KJ, Fornito A, Merlo-Pich E, Fineberg NA, Shabbir SS, Robbins TW, Bullmore ET. Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder. Neuroimage. 59: 1461-8. PMID 21871569 DOI: 10.1016/j.neuroimage.2011.08.003  0.52
2012 Nathan PJ, O'Neill BV, Mogg K, Bradley BP, Beaver J, Bani M, Merlo-Pich E, Fletcher PC, Swirski B, Koch A, Dodds CM, Bullmore ET. The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 149-61. PMID 21745436 DOI: 10.1017/S1461145711001052  0.52
2012 Gomeni R, Merlo-Pich E. Trial Simulation to estimate Type I error when a population window enrichment strategy is used to improve efficiency of clinical trials in depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 44-52. PMID 21636257 DOI: 10.1016/j.euroneuro.2011.05.002  0.52
2012 Inkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, et al. Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease. Neurobiology of Aging. 33: 457-65. PMID 20570408 DOI: 10.1016/j.neurobiolaging.2010.04.018  0.52
2011 Merlo Pich E. Understanding pharmacology in humans: Phase I and Phase II (data generation). Current Opinion in Pharmacology. 11: 557-62. PMID 21783419 DOI: 10.1016/j.coph.2011.06.010  0.52
2011 Costantini VJA, Vicentini E, Sabbatini FM, Valerio E, Lepore S, Tessari M, Sartori M, Michielin F, Melotto S, Merlo Pich E, Corsi M. GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs Neuroendocrinology. 94: 158-168. PMID 21778696 DOI: 10.1159/000328968  0.52
2011 Cazzin C, Piccoli L, Massagrande M, Garbati N, Michielin F, Knaus HG, Ring CJ, Morrison AD, Merlo-Pich E, Rovo Z, Astori S, Lüthi A, Corti C, Corsi M. rKv1.2 overexpression in the central medial thalamic area decreases caffeine-induced arousal. Genes, Brain, and Behavior. 10: 817-27. PMID 21762462 DOI: 10.1111/j.1601-183X.2011.00719.x  0.52
2011 Roberts C, Inamdar A, Koch A, Kitchiner P, Dewit O, Merlo-Pich E, Fina P, McFerran DJ, Baguley DM. A randomized, controlled study comparing the effects of vestipitant or vestipitant and paroxetine combination in subjects with tinnitus. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 32: 721-7. PMID 21646935 DOI: 10.1097/MAO.0b013e318218a086  0.52
2011 Valenzuela M, Bartrés-Faz D, Beg F, Fornito A, Merlo-Pich E, Müller U, Öngür D, Toga AW, Yücel M. Neuroimaging as endpoints in clinical trials: are we there yet? Perspective from the first Provence workshop. Molecular Psychiatry. 16: 1064-6. PMID 21625230 DOI: 10.1038/mp.2011.62  0.52
2011 Catafau AM, Bullich S, Nucci G, Burgess C, Gray F, Merlo-Pich E. Contribution of SPECT measurements of D2 and 5-HT2A occupancy to the clinical development of the antipsychotic SB-773812. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 526-34. PMID 21421726 DOI: 10.2967/jnumed.110.081885  0.52
2011 Inkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM. Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 21: 375-82. PMID 20977527 DOI: 10.1111/j.1552-6569.2010.00515.x  0.52
2010 Micheli F, Di Fabio R, Giacometti A, Roth A, Moro E, Merlo G, Paio A, Merlo-Pich E, Tomelleri S, Tonelli F, Zarantonello P, Zonzini L, Capelli AM. Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones: a new class of Neuropeptide S antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 7308-11. PMID 21055936 DOI: 10.1016/j.bmcl.2010.10.067  0.52
2010 Merlo-Pich E, Alexander RC, Fava M, Gomeni R. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clinical Pharmacology and Therapeutics. 88: 634-42. PMID 20861834 DOI: 10.1038/clpt.2010.159  0.52
2010 Searle G, Beaver JD, Comley RA, Bani M, Tziortzi A, Slifstein M, Mugnaini M, Griffante C, Wilson AA, Merlo-Pich E, Houle S, Gunn R, Rabiner EA, Laruelle M. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. Biological Psychiatry. 68: 392-9. PMID 20599188 DOI: 10.1016/j.biopsych.2010.04.038  0.52
2010 Micheli F, Cavanni P, Andreotti D, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Carletti R, Checchia A, Corsi M, Fazzolari E, Fontana S, et al. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. Journal of Medicinal Chemistry. 53: 4989-5001. PMID 20527970 DOI: 10.1021/jm100481d  0.52
2010 Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, Brittain C, Rujescu D, Giegling I, Turck CW, Holsboer F, Bullmore ET, Middleton L, Merlo-Pich E, Alexander RC, et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. Plos One. 5: e9166. PMID 20161799 DOI: 10.1371/journal.pone.0009166  0.52
2009 Janes AC, Frederick Bd, Richardt S, Burbridge C, Merlo-Pich E, Renshaw PF, Evins AE, Fava M, Kaufman MJ. Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence. Experimental and Clinical Psychopharmacology. 17: 365-73. PMID 19968401 DOI: 10.1037/a0017797  0.52
2009 Vicentini E, Arban R, Angelici O, Maraia G, Perico M, Mugnaini M, Ugolini A, Large C, Domenici E, Gerrard P, Bortner D, Mansuy IM, Mangiarini L, Merlo-Pich E. Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice. Pharmacology, Biochemistry, and Behavior. 93: 17-24. PMID 19358863 DOI: 10.1016/j.pbb.2009.03.015  0.52
2009 Furmark T, Henningsson S, Appel L, Ahs F, Linnman C, Pissiota A, Faria V, Oreland L, Bani M, Pich EM, Eriksson E, Fredrikson M. Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder. Journal of Psychiatry & Neuroscience : Jpn. 34: 30-40. PMID 19125211  0.52
2009 Grilli M, Pittaluga A, Merlo-Pich E, Marchi M. NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment. Journal of Neurochemistry. 108: 408-16. PMID 19046354 DOI: 10.1111/j.1471-4159.2008.05792.x  0.52
2009 Gomeni R, Lavergne A, Merlo-Pich E. Modelling placebo response in depression trials using a longitudinal model with informative dropout. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 36: 4-10. PMID 19041717 DOI: 10.1016/j.ejps.2008.10.025  0.52
2009 Fontana F, Bernardi P, Pizzi C, Di Toro R, Spampinato S, Merlo Pich E. Plasma brain natriuretic peptide at rest and after adenosine-induced myocardial ischemia in normotensive and essential hypertensive patients with suspected coronary artery disease. Peptides. 30: 385-90. PMID 18951935 DOI: 10.1016/j.peptides.2008.09.018  0.52
2008 Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, Pissiota A, Frans O, Bani M, Bettica P, Pich EM, Jacobsson E, Wahlstedt K, Oreland L, LÃ¥ngström B, et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13066-74. PMID 19052197 DOI: 10.1523/JNEUROSCI.2534-08.2008  0.72
2008 Merlo-Pich E, Gomeni R. Model-based approach and signal detection theory to evaluate the performance of recruitment centers in clinical trials with antidepressant drugs. Clinical Pharmacology and Therapeutics. 84: 378-84. PMID 18449185 DOI: 10.1038/clpt.2008.70  0.52
2008 Catafau AM, Penengo MM, Nucci G, Bullich S, Corripio I, Parellada E, García-Ribera C, Gomeni R, Merlo-Pich E. Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients. Journal of Psychopharmacology (Oxford, England). 22: 882-94. PMID 18308793 DOI: 10.1177/0269881107083810  0.52
2008 Chen CH, Suckling J, Ooi C, Fu CH, Williams SC, Walsh ND, Mitterschiffthaler MT, Pich EM, Bullmore E. Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1909-18. PMID 17987064 DOI: 10.1038/sj.npp.1301593  0.72
2007 Walsh ND, Williams SC, Brammer MJ, Bullmore ET, Kim J, Suckling J, Mitterschiffthaler MT, Cleare AJ, Pich EM, Mehta MA, Fu CH. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biological Psychiatry. 62: 1236-43. PMID 17601497 DOI: 10.1016/j.biopsych.2006.12.022  0.72
2007 Gomeni R, Merlo-Pich E. Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. British Journal of Clinical Pharmacology. 63: 595-613. PMID 17488364 DOI: 10.1111/j.1365-2125.2006.02815.x  0.52
2007 Fu CH, Williams SC, Brammer MJ, Suckling J, Kim J, Cleare AJ, Walsh ND, Mitterschiffthaler MT, Andrew CM, Pich EM, Bullmore ET. Neural responses to happy facial expressions in major depression following antidepressant treatment. The American Journal of Psychiatry. 164: 599-607. PMID 17403973 DOI: 10.1176/appi.ajp.164.4.599  0.72
2007 Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, Bullmore E. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry. 62: 407-14. PMID 17217921 DOI: 10.1016/j.biopsych.2006.09.018  0.52
2006 Collo G, Goffi F, Merlo Pich E, Baldelli P, Benfenati F, Spano P. Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro. Brain Research. 1109: 32-6. PMID 16859654 DOI: 10.1016/j.brainres.2006.06.064  0.52
2006 Salaria S, Chana G, Caldara F, Feltrin E, Altieri M, Faggioni F, Domenici E, Merlo-Pich E, Everall IP. Microarray analysis of cultured human brain aggregates following cortisol exposure: implications for cellular functions relevant to mood disorders. Neurobiology of Disease. 23: 630-6. PMID 16844382 DOI: 10.1016/j.nbd.2006.05.003  0.52
2005 Poma SZ, Milleri S, Squassante L, Nucci G, Bani M, Perini GI, Merlo-Pich E. Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects. Journal of Psychopharmacology (Oxford, England). 19: 494-503. PMID 16166187 DOI: 10.1177/0269881105056533  0.52
2005 Furmark T, Appel L, MichelgÃ¥rd A, Wahlstedt K, Ahs F, Zancan S, Jacobsson E, Flyckt K, Grohp M, Bergström M, Pich EM, Nilsson LG, Bani M, LÃ¥ngström B, Fredrikson M. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biological Psychiatry. 58: 132-42. PMID 16038684 DOI: 10.1016/j.biopsych.2005.03.029  0.72
2004 Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry. 61: 877-89. PMID 15351766 DOI: 10.1001/archpsyc.61.9.877  0.72
2002 Mugnaini M, Tessari M, Tarter G, Merlo Pich E, Chiamulera C, Bunnemann B. Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. The European Journal of Neuroscience. 16: 1633-46. PMID 12431215 DOI: 10.1046/j.1460-9568.2002.02220.x  0.52
2002 Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology. 160: 113-21. PMID 11875628 DOI: 10.1007/s00213-001-0940-y  0.52
2001 Salmon AM, Damaj MI, Marubio LM, Epping-Jordan MP, Merlo-Pich E, Changeux JP. Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice. Nature Neuroscience. 4: 357-8. PMID 11276224 DOI: 10.1038/86001  0.52
2001 Tacconi S, Carletti R, Bunnemann B, Plumpton C, Merlo Pich E, Terstappen GC. Distribution of the messenger RNA for the small conductance calcium-activated potassium channel SK3 in the adult rat brain and correlation with immunoreactivity. Neuroscience. 102: 209-15. PMID 11226685 DOI: 10.1016/S0306-4522(00)00486-3  0.52
2000 Fontana F, Bernardi P, Tartuferi L, Boschi S, De Iasio R, Merlo Pich E. Mechanisms of hypertension in patients with chronic obstructive pulmonary disease and acute respiratory failure. The American Journal of Medicine. 109: 621-7. PMID 11099681 DOI: 10.1016/S0002-9343(00)00608-2  0.52
2000 Bunnemann B, Terron A, Zantedeschi V, Merlo Pich E, Chiamulera C. Chronic nicotine treatment decreases neurofilament immunoreactivity in the rat ventral tegmental area. European Journal of Pharmacology. 393: 249-53. PMID 10771021 DOI: 10.1016/S0014-2999(00)00104-7  0.52
2000 Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 230-9. PMID 10693150 DOI: 10.1016/S0893-133X(99)00108-6  0.72
1999 Boschert U, Merlo-Pich E, Higgins G, Roses AD, Catsicas S. Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiology of Disease. 6: 508-14. PMID 10600406 DOI: 10.1006/nbdi.1999.0251  0.52
1999 le Novère N, Zoli M, Léna C, Ferrari R, Picciotto MR, Merlo-Pich E, Changeux JP. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. Neuroreport. 10: 2497-501. PMID 10574359  0.52
1998 Ghersa P, Gobert RP, Sattonnet-Roche P, Richards CA, Merlo Pich E, Hooft van Huijsduijnen R. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Therapy. 5: 1213-20. PMID 9930322 DOI: 10.1038/sj.gt.3300713  0.52
1998 Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytiä P, Merlo-Pich E, Weiss F. Neurocircuitry targets in ethanol reward and dependence. Alcoholism, Clinical and Experimental Research. 22: 3-9. PMID 9514280  0.72
1998 Fontana F, Bernardi P, Merlo Pich E, Boschi S, De Iasio R, Spampinato S. Endogenous opioid peptides and mental stress in congestive heart failure patients Peptides. 19: 21-26. PMID 9437733 DOI: 10.1016/S0196-9781(97)00251-9  0.52
1996 Heinrichs SC, Stenzel-Poore MP, Gold LH, Battenberg E, Bloom FE, Koob GF, Vale WW, Pich EM. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74: 303-11. PMID 8865183 DOI: 10.1016/0306-4522(96)00140-6  0.52
1996 Collo G, North RA, Kawashima E, Merlo-Pich E, Neidhart S, Surprenant A, Buell G. Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 2495-507. PMID 8786426  0.52
1996 Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (New York, N.Y.). 273: 1561-4. PMID 8703220  0.72
1996 Rodríguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. The Journal of Pharmacology and Experimental Therapeutics. 276: 56-64. PMID 8558457  0.72
1995 Heinrichs SC, Menzaghi F, Merlo Pich E, Britton KT, Koob GF. The role of CRF in behavioral aspects of stress. Annals of the New York Academy of Sciences. 771: 92-104. PMID 8597448 DOI: 10.1111/j.1749-6632.1995.tb44673.x  0.72
1995 Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 5439-47. PMID 7643193  0.72
1995 Biagini G, Merlo Pich E, Frasoldati A, Agnati LF, Marrama P. Changes in glucocorticoid receptor immunoreactivity after adrenalectomy and corticosterone treatment in the rat testis. Journal of Endocrinological Investigation. 18: 384-90. PMID 7594229 DOI: 10.1007/BF03347843  0.52
1994 Menzaghi F, Heinrichs SC, Merlo-Pich E, Tilders FJ, Koob GF. Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats. Neuroscience Letters. 168: 139-42. PMID 8028766 DOI: 10.1016/0304-3940(94)90435-9  0.72
1993 Zoli M, Merlo Pich E, Ferraguti F, Biagini G, Fuxe K, Agnati LF. Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat. Neurochemistry International. 23: 139-48. PMID 8369738 DOI: 10.1016/0197-0186(93)90091-I  0.52
1993 Pich EM, Heinrichs SC, Rivier C, Miczek KA, Fisher DA, Koob GF. Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats. Psychoneuroendocrinology. 18: 495-507. PMID 8265737 DOI: 10.1016/0306-4530(93)90043-K  0.52
1992 Fuxe K, Von Euler G, Agnati LF, Merlo Pich E, O'Connor WT, Tanganelli S, Li XM, Tinner B, Cintra A, Carani C. Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin. Annals of the New York Academy of Sciences. 668: 186-204. PMID 1361113 DOI: 10.1111/j.1749-6632.1992.tb27350.x  0.52
1990 Merlo Pich E, Solfrini V, Biagini G, Fuxe K, Agnati LF. Effects of indole-pyruvic acid on sleep and food intake in the rat. Acta Physiologica Scandinavica. 139: 583-9. PMID 2248038 DOI: 10.1111/j.1748-1716.1990.tb08962.x  0.52
1990 Fuxe K, Agnati LF, Härfstrand A, Zoli M, von Euler G, Grimaldi R, Merlo Pich E, Bjelke B, Eneroth P, Benfenati F. On the role of neuropeptide Y in information handling in the central nervous system in normal and physiopathological states. Focus on volume transmission and neuropeptide Y/alpha 2 receptor interactions. Annals of the New York Academy of Sciences. 579: 28-67. PMID 2159745 DOI: 10.1111/j.1749-6632.1990.tb48351.x  0.52
1990 Ruggeri M, Merlo Pich E, Zini I, Fuxe K, Ungerstedt U, Agnati LF. Indole-pyruvic acid increases 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid and frontoparietal cortex of the rat: a microdialysis study. Acta Physiologica Scandinavica. 138: 97-8. PMID 1689925 DOI: 10.1111/j.1748-1716.1990.tb08818.x  0.52
1989 Zoli M, Grimaldi R, Agnati LF, Zini I, Merlo Pich E, Toffano G, Fuxe K. Neurohistochemical studies on striatal lesions induced by transient forebrain ischemia. Evidence for protective effects of the ganglioside analogue AGF2 Neuroscience Research Communications. 4: 153-158.  0.52
1988 Agnati LF, Zini I, Zoli M, Fuxe K, Merlo Pich E, Grimaldi R, Toffano G, Goldstein M. Regeneration in the central nervous system: concepts and facts. Advances and Technical Standards in Neurosurgery. 16: 3-50. PMID 3064755  0.52
1987 Fuxe K, Agnati LF, Merlo Pich E, Meller E, Goldstein M. Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat. Neuroscience Letters. 81: 183-7. PMID 3320818 DOI: 10.1016/0304-3940(87)90362-4  0.52
1986 Sacquegna T, D'Addato M, Baldrati A, Cortelli P, Lamieri C, Merlo Pich E, Vitacchiano G, Pedrini L. Long-term prognosis after carotid endarterectomy. European Neurology. 25: 36-9. PMID 3940863 DOI: 10.1159/000115984  0.52
1986 Esposito E, Romandini S, Merlo-Pich E, Mennini T, Samanin R. Evidence of the involvement of dopamine in the analgesic effect of nefopam. European Journal of Pharmacology. 128: 157-64. PMID 3098570  0.52
1984 Agnati LF, Fuxe K, Benfenati F, Toffano G, Cimino M, Battistini N, Calza L, Merlo Pich E. Studies on aging processes. Acta Physiologica Scandinavica. Supplementum. 532: 45-61. PMID 6093434  0.52
Show low-probability matches.